What is the stock price trajectory of Cognyte Software Ltd. (CGNT)?

Cognyte Software Ltd. [CGNT] stock prices are up 0.51% to $3.91 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CGNT shares have gain 8.01% over the last week, with a monthly amount glided 22.57%, and seem to be holding up well over a long-time horizon.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


On 5, January 2023, Cognyte to Participate in the 25th Annual Needham Growth Conference. In a post published today on Yahoo Finance, Cognyte Software Ltd. (NASDAQ: CGNT) (“Cognyte”), a global leader in investigative analytics software, today announced that Elad Sharon, Cognyte’s Chief Executive Officer, and David Abadi, Cognyte’s Chief Financial Officer, will hold a virtual fireside chat at the Needham Growth Conference on Thursday, January 12, 2023, at 8:45 am ET. An online, real-time webcast and replay of the virtual discussion will be available on the Investors page of our website.

From an analyst’s perspective:

Cognyte Software Ltd. [NASDAQ: CGNT] stock has seen the most recent analyst activity on September 29, 2022, when Stifel downgraded its rating to a Hold and also revised its price target to $6 from $8. Previously, Evercore ISI downgraded its rating to In-line on June 29, 2022, and dropped its price target to $5. On June 28, 2022, downgrade downgraded it’s rating to Mkt Perform. Needham downgraded its rating to a Hold. Wedbush downgraded its rating to a Neutral but $17 remained the price target by the analyst firm on December 22, 2021. In a note dated March 05, 2021, Evercore ISI upgraded an Outperform rating on this stock but restated the target price of $40.

The stock price of Cognyte Software Ltd. [CGNT] has been fluctuating between $2.31 and $12.82 over the past year. Currently, Wall Street analysts expect the stock to reach $3.00 within the next 12 months. Cognyte Software Ltd. [NASDAQ: CGNT] shares were valued at $3.91 at the most recent close of the market. An investor can expect a potential drop of -23.27% based on the average CGNT price forecast.

Analyzing the CGNT fundamentals

The most recent quarter, Cognyte Software Ltd. [NASDAQ:CGNT] reported sales of 71.25 billion, representing a drop of -39.80%. Gross Margin for this corporation currently stands at +69.05% with Operating Margin at +6.68%, Pretax Margin comes in at +1.74%, and Net Margin reading is -3.14%.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.83 points at the first support level, and at 3.76 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.03, and for the 2nd resistance point, it is at 4.15.

Cognyte Software Ltd. [CGNT] reported earnings per share of -$0.04 for its fiscal quarter that ended on 7/30/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.17/share, meaning a difference of $0.13 and a surprise factor of 76.50%. By comparison, the stated earnings for the previous quarter ended on 4/29/2022 were -$0.79 per share as compared to estimates of $0.1 per share, a difference of -$0.89 representing a surprise of -890.00%.

Ratios To Look Out For

It’s worth pointing out that Cognyte Software Ltd. [NASDAQ:CGNT]’s Current Ratio is 1.30. As well, the Quick Ratio is 1.26, while the Cash Ratio is 0.52. Considering the valuation of this stock, the price to sales ratio is 1.52, the price to book ratio is 2.56.